CVS Health Confirms It Is Exploring Aetna Spin-Off
CVS Health is reportedly exploring a spin-off of its Aetna insurance arm, according to people familiar with the matter, as the healthcare conglomerate faces mounting pressure to unlock shareholder value. The move, which would separate the pharmacy giant from the health insurer it acquired for $69 billion in 2018, comes as CVS struggles with rising medical costs and a depressed stock price.
The plans, first reported by The Wall Street Journal, are still in early stages and could change, the sources said. CVS declined to comment on the speculation. The company's shares jumped nearly 4% on the news, reflecting investor optimism that a breakup could help both businesses thrive independently.
A CVS-Aetna separation would mark a major reversal for the company, which bet big on vertical integration when it bought the insurer six years ago. At the time, the deal was pitched as a way to create a seamless healthcare experience, combining CVS's pharmacies and clinics with Aetna's insurance network. But the synergies have been slow to materialize, and the company's stock has lagged peers.
The Numbers Behind the Pressure
The spin-off talks come as CVS Health's financial performance has diverged from its peers. According to a Trefis analysis, CVS ranks second of four in revenue growth among a peer group that includes UnitedHealth Group, Cigna, and Walmart, with revenue growing 7.4% over the latest four fiscal quarters. Cigna grew 7.7% over the same period. However, CVS's operating margin of 3.4% lags UnitedHealth's 4.8% and Walmart's 4.4%.
CVS's stock has delivered a total return of 15.4% between October 2025 and October 2026, compared with 17.6% for UnitedHealth and 2.0% for Cigna. But the company's valuation is distorted by a $3.97 billion net loss in fiscal Q3 2025, which included a $5.7 billion goodwill impairment in its Health Care Delivery business. That non-cash charge has made CVS's trailing P/E ratio of 23.6 look inflated relative to Cigna's 12.2, even though the underlying operating performance is similar.
Aetna's Struggles
Aetna has been a drag on CVS's results. The insurer has faced higher-than-expected medical costs, particularly in its Medicare Advantage business, as seniors return to hospitals for procedures deferred during the pandemic. In 2025, CVS's Health Services segment, which includes Aetna, generated $190 billion in revenue but saw margins squeezed.
The company has been trying to turn around Aetna by raising premiums, cutting costs, and exiting unprofitable markets. But the improvements have been slow, and investors have grown impatient. Activist investor Glenview Capital Management, which built a stake in CVS last year, has been pushing for changes, including a potential separation of Aetna.
The Case for a Spin-Off
A spin-off of Aetna would create two separate companies: one focused on pharmacy and healthcare services (CVS Health) and one focused on insurance (Aetna). Proponents argue that the two businesses have different risk profiles and capital needs, and that separating them would allow each to pursue its own strategy.
CVS Health's pharmacy and retail business is a steady cash generator, but it faces challenges from drug pricing pressure and competition from online retailers. Aetna, on the other hand, is a cyclical business that is more sensitive to medical cost trends. By separating, each company could be valued on its own merits, potentially unlocking value for shareholders.
Management's Options
CVS has been exploring a range of options, including a sale of Aetna, a spin-off, or keeping the insurer and continuing to invest in it. The company has not made a final decision, and the talks are fluid. A spin-off could take months to execute and would require regulatory approvals.
A CVS spokesperson said the company does not comment on rumors or speculation. Aetna did not respond to a request for comment.
Broader Implications for the Healthcare Industry
A CVS-Aetna spin-off would be the latest in a series of healthcare mergers and separations as companies reassess their strategies. In recent years, several large healthcare conglomerates have broken up, including Johnson & Johnson's separation of its consumer health business and General Electric's split into three companies. The trend reflects a growing recognition that size and diversification are not always advantages, and that focused companies can create more value.
For CVS, a separation would allow it to focus on its core pharmacy and healthcare services business, which includes its MinuteClinics and HealthHUBs. The company has been investing heavily in these areas, including a $1.1 million investment in affordable housing in Hammond, Louisiana, as part of its community health efforts. In November 2026, CVS Health and Aetna Better Health of Louisiana hosted a "Ball Out for Better Health" fair at Phoenix Square, providing health screenings and flu vaccinations to residents.
What Changes for Consumers
For consumers, a spin-off could mean changes in how they interact with CVS and Aetna. If the companies separate, Aetna members might have different options for pharmacy benefits, and CVS pharmacies might not be the preferred network for Aetna plans. However, the companies could also maintain a commercial relationship, similar to the one CVS has with other insurers.
Aetna's 39 million members would become customers of a standalone insurer, which could lead to more competitive pricing and innovation. CVS's pharmacy customers would continue to use its stores and clinics, but the company might pursue new partnerships with other insurers.
What to Watch
Investors will be watching for any official announcement from CVS about its plans. The company is scheduled to report its fourth-quarter earnings in February 2027, and management may provide an update on its strategic review at that time. Analysts will also be looking for signs of improvement in Aetna's medical cost trends, which could affect the timing and structure of any separation.
For now, the speculation has lifted CVS's stock, but the company has a long way to go to convince investors that a breakup is the right path. The healthcare landscape is evolving rapidly, and CVS's ability to adapt will determine its future—whether as a combined company or as two separate ones.
A Note on the Numbers
It's worth noting that CVS's recent financial performance has been mixed. While revenue growth has been solid, the company's operating margin has been under pressure. In fiscal Q2 2026, CVS reported an operating margin of 4.4%, up from 2.4% in the prior year, but the four-quarter margin still includes the impact of the 2025 impairment. As the company moves past these one-time charges, its true profitability will become clearer.
For a company that once touted the benefits of vertical integration, the exploration of a spin-off is a tacit admission that the strategy has not delivered as hoped. But it also represents an opportunity for CVS to reset and focus on what it does best: providing accessible, affordable healthcare to millions of Americans.
The coming months will be critical for CVS Health as it decides whether to double down on its integrated model or chart a new course. Either way, the healthcare industry will be watching closely.
Comments